Margriet van Laar

3.7k citations
90 papers · 2.4k indexed · h-index 25
Topics
Substance Abuse Treatment and Outcomes (35 papers)Cannabis and Cannabinoid Research (29 papers)Homelessness and Social Issues (21 papers)

In The Last Decade

Margriet van Laar

81 papers receiving 2.3k citations

Peers

Margriet van Laar
Comparison fields: 5 of 139
  • Pharmacology 1.4k
  • Epidemiology 782
  • Clinical Psychology 484
  • General Health Professions 394
  • Toxicology 346
Replace Michel Reynaud with:
Michel Reynaud France
Benjamin Rolland France
Didier Jutras‐Aswad Canada
Gerhard A. Wiesbeck Switzerland
Russell C. Callaghan Canada
Amine Benyamina France
Sean P. Barrett Canada
Gantt P. Galloway United States
Flávio Pechansky Brazil
Robert L. DuPont United States
Margriet van Laar relative to Michel Reynaud France Michel Reynaud's profile →
Citations per field
00.5×1.5×2.1×
Michel Reynaud · 1×
Citations per year

Countries citing papers authored by Margriet van Laar

Since Specialization
Citations

This map shows the geographic impact of Margriet van Laar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margriet van Laar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margriet van Laar more than expected).

Fields of papers citing papers by Margriet van Laar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margriet van Laar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margriet van Laar. The network helps show where Margriet van Laar may publish in the future.

Co-authorship network of co-authors of Margriet van Laar

This figure shows the co-authorship network connecting the top 25 collaborators of Margriet van Laar. A scholar is included among the top collaborators of Margriet van Laar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margriet van Laar. Margriet van Laar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 4
3 1
4 4
5 7
6 2
7 5
8 6
9 10
10 10
11 92
12
Points of sale of tobacco products: Synthesis of scientific and practice based knowledge on the impact of reducing the number of points of sale and restrictions on tobacco product displays
8
13 69
14 24
15
The Netherlands drug situation 2009
4
16 9
17
Evaluatie van het Nederlandse drugsbeleid
22
18
Drug situation 2006 - the Netherlands
1
19
Nationale Drug Monitor : Jaarbericht 2007
20
20
A METHODICAL COMPARATIVE STUDY OF OVER-THE-ROAD AND SIMULATED DRIVING PERFORMANCE AFTER NOCTURNAL TREATMENT WITH LORMETAZEPAM 1MG AND OXAZEPAM 50MG
1

About Margriet van Laar

Margriet van Laar is a scholar working on Toxicology, Pharmacology and Applied Psychology, having authored 90 papers that have together received 2.4k indexed citations. Recurring topics across this work include Substance Abuse Treatment and Outcomes (35 papers), Cannabis and Cannabinoid Research (29 papers) and Homelessness and Social Issues (21 papers). The work is most often cited by research in Toxicology (346 citations), Pharmacology (1.4k citations) and Applied Psychology (136 citations). Margriet van Laar has collaborated with scholars based in Netherlands, United Kingdom and Slovenia. Frequent co-authors include Peggy van der Pol, Olaf H. Drummer, G Berghaus, Johannes G. Ramaekers, Raymond J.M. Niesink, Wim van den Brink, Dirk J. Korf, Nienke Liebregts, Ron de Graaf and Edmund R. Volkerts. Their work appears in journals such as PLoS ONE, Psychological Medicine and American Journal of Preventive Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026